During Tuesday’s Morning trade, Shares of Southwest Airlines Co (NYSE:LUV), lost -0.09% to $46.33.
Southwest Airlines, is bringing not one, but two daily flights from Baltimore/Washington to Minneapolis/St. Paul. The new, twice-daily, nonstop service starts on April 12, 2016, with fares as low as $79 one-way.
Purchase Nov.9 through Nov. 19, 2015, 11:59 p.m. in the respective time zone of the originating city. Travel April 12 through May 26, 2016. Travel is not valid on Fridays and Sundays. Fares are valid on nonstop, domestic service only. Displayed prices comprise all U.S. government taxes and fees. Points bookings do not comprise September 11th Security Fee of $5.60 per one-way flight. Seats and days are limited. See additional and complete fare rules below.
“At Southwest the bare facts are simply that two checked bags, airport check-in, carry-on bags, ticket changes, non-alcoholic drinks, and of course snacks are NOT so-called optional services, “said Andrew Watterson, Southwest Airlines Senior Vice President of Network and Revenue Administration. “We believe that it’s not in the holiday spirit to charge bag fees for the first two checked bags*, much less even higher bag fees, during the holiday season.”
These new flights bring even more access to Customers flying from the Twin Cities with one-stop connections and same-plane service to more than 60 nonstop destinations served from Baltimore/Washington International Thurgood Marshall Airport. These comprise flights to the Caribbean and Latin America, counting Southwest’s newest destination, Liberia, Costa Rica.
Southwest Airlines Co. operates passenger airlines that provide planned air transportation services in the United States and near-international markets. As of December 31, 2014, it operated 665 Boeing 737 aircraft; and had 12 Boeing 717 aircraft. The company served 93 destinations in 40 states, the District of Columbia, and the Commonwealth of Puerto Rico, in addition to 5 near-international countries, counting Mexico, Jamaica, The Bahamas, Aruba, and the Dominican Republic.
Shares of ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), declined -2.76% to $61.05, during its current trading session.
Isis Pharmaceuticals, declared that it has earned a $2.8 million milestone payment from Biogen related to the advancement of the ongoing Phase 1/2a study of ISIS-DMPK-2.5Rx in patients with myotonic dystrophy type I (DM1).
“Our partnershipwith Biogen has been very productive. ISIS-DMPK-2.5Rx has rapidly advanced into patients with DM1, and we continue to make progress across the board in our drug discovery programs with Biogen. Progress like this advances our severe and rare disease pipeline for neurological disorders, which may, as our programs advance, translate into the potential for noteworthy revenue. Together with Biogen, we have advanced four drugs into the pipeline and have other targets in late-stage research. To date and counting the $2.8 million earned recently, we have generated nearly $27 million from Biogen related to the advancement of ISIS-DMPK-2.5Rx,” said B. Lynne Parshall, chief operating officer at Isis Pharmaceuticals.
ISIS-DMPK-2.5Rx is designed to reduce the production of the toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells, counting muscle cells, for the potential treatment of DM1. ISIS-DMPK-2.5Rx is being evaluated in a randomized, placebo-controlled, dose-escalation Phase 1/2a study in patients with DM1. For further study information, please visit www.clinicaltrials.gov and search for ISIS-DMPKRx or by the study number: NCT02312011.
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product comprises the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia; and for the reduction of low-density lipoprotein cholesterol. It also has a pipeline of 38 drugs in development for the treatment of various diseases, counting cardiovascular and metabolic diseases; severe and rare diseases, which comprise neurological disorders; and cancer.
Finally, Shares of Liberty Global plc (NASDAQ:LBTYK), gained 0.39%, and is now trading at $43.99.
Liberty Global plc, Discovery Communications Inc. and Lions Gate Entertainment Corp. (“Lionsgate”) (LGF), declared a transaction under which Liberty Global and Discovery Communications each have agreed in principle subject to documentation to purchase 5.0 million common shares of Lionsgate, resulting in each having an about 3.4% shareholding of Lionsgate’s current outstanding shares. These 10.0 million shares will be attained from funds associated with MHR Fund Administration LLC.
Liberty Global plc, together with its auxiliaries, provides video, broadband Internet, fixed-line telephony, and mobile services in Europe, Chile, Puerto Rico, and internationally. The company offers various residential services, counting video services comprising basic and premium programming, which can be viewed on the television and Internet connected devices; electronic programming guide, high definition (HD) channels, digital video recorder (DVR), and HD DVR services; video-on-demand, set-top boxes, pay-per-view programming, and programming in three-dimensional format services, in addition to television applications that allow access to programming on laptops, smart phones, and tablets; and entertainment, sports, movies, documentaries, lifestyles, news, adult, children, and ethnic and foreign channels.